Fluent Financial’s Amgen AMGN Stock Holding History

Fluent Financial’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,300	Closed	-$74K	–	52
2020 Q1	$74K	Buy	+8,300	New	+$1.81M	0.05%	55

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fluent Financial's AMGN Position: Q1 2022 in Review

Fluent Financial sold out of Amgen (AMGN) in Q1 2022, closing a stake of 10,764 shares — an estimated $2.42M sold.

Fluent Financial first reported a position in AMGN in Q4 2017 and held it in 12 quarters. The position peaked at $7.12M in Q3 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

Fluent Financial reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
Fluent Financial sold 10,764 Amgen shares in Q1 2022, an estimated $2.42M.
Fluent Financial first reported a position in Amgen in Q4 2017 and held it in 12 quarters.
Fluent Financial's Amgen position peaked at $7.12M in Q3 2021.
2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Fluent Financial's 13F filing for Q1 2022, filed 10 May 2022.